ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag induced pluripotent stem cell disease medicine neuroscience ecology

Synthego Launches High Throughput Induced Pluripotent Stem Cell Genome Engineering
Synthego | Oct 29, 2019 | 2 min read
National Institutes of Health awards contract for CRISPR-based disease modeling in iPS cell lines associated with Alzheimer’s, Stem cell pioneer Bill Skarnes joins advisory board
Sergiu Pasca Builds Brains to Study Developmental Disease
Emily Makowski | Dec 1, 2019 | 3 min read
The Stanford University professor helped develop a technique to grow brain organoids from induced pluripotent stem cells.
Stem Cell Trial for Eye Disease Commences
Jef Akst | Sep 12, 2014 | 2 min read
Researchers at the RIKEN Center for Developmental Biology will treat the first patient in its clinical trial testing an induced pluripotent stem cell-based treatment for age-related macular degeneration.
Use of Induced Pluripotent Stem Cells in Drug Discovery: Challenges and Opportunities
The Scientist Marketing Team | Sep 26, 2013 | 3 min read
The Scientist brings together a panel of experts who parse the hope and hype in an effort to educate the audience about the successes and caveats of using iPSCs.
Stem Cell Transplant Treats Parkinson’s Disease in Monkeys
Roni Dengler, PhD | Feb 7, 2022 | 4 min read
Personalized stem cells improved motor symptoms and depression signs in monkeys modeling Parkinson’s disease, paving the way for trials in human patients.
Harnessing Stem Cells to Model Neurological Disorders
The Scientist | Apr 15, 2021 | 2 min read
Banking on iPSCs
Kerry Grens | Jun 29, 2014 | 6 min read
A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.
Banking on iPSCs
Kerry Grens | Sep 1, 2014 | 5 min read
A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.
Bespoke Stem Cells for Brain Disease
Nsikan Akpan | Jan 14, 2013 | 3 min read
Scientists use virus-free gene therapy on patient-derived stem cells to repair spinal muscular atrophy in mice.
Modeling Disease and Dysfunction with iPSC-derived, Induced Neural Progenitor Cells
The Scientist Marketing Team | May 23, 2016 | 1 min read
To explore the pros and cons of using iNPCs as a model for neuronal function and dysfunction, The Scientist is bringing together a panel of experts to share their experience with iNPCs and their forecast for iNPC disease modelling for human disease.

Run a Search

ADVERTISEMENT